Basic Information
Bryn Pharma Offers a Better Way to Empower Patients at Risk of Anaphylaxis. It is the developer of a dual-dose intranasal device for the treatment of anaphylaxis. The company's device is small enough to comfortably fit in a pocket and easy to use during an anaphylactic episode, enabling patients to better manage their daily lives.
Bryn Pharma LLC
California,United States of America
less than 15 people
January 01, 2017
info@brynpharma.com

